cladribine 10 MG (10) Oral Tablet Pack

RxCUI
2122660
RxNorm name
cladribine 10 MG (10) Oral Tablet Pack
Display name
cladribine 10 MG (10) Oral Tablet Pack
Full name
cladribine 10 MG (10) Oral Tablet Pack
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CladribineCLADRIBINESandoz Inc.e0b363cb-db83-44d6-89d0-1f7176be74592026-06-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2122660
CladribineCLADRIBINEApotex Corp.407c52d5-6498-7da5-da35-acc9ca73ced32026-06-08Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2122660
MavencladCLADRIBINEEMD Serono, Inc.9c75e30a-a410-40f1-b653-04d532bd91442026-05-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2122660
CladribineCLADRIBINEGenvion Corporationf1d650a5-4205-720b-f39b-4213277b66122025-12-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2122660

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9c75e30a-a410-40f1-b653-04d532bd9144{10 (cladribine 10 MG Oral Tablet) } PackGPCK10These highlights do not include all the information needed to use MAVENCLAD safely and effectively. See full prescribing information for MAVENCLAD. MAVENCLAD ® (cladribine) tablets, for oral use Initial U.S. Approval: 199320260527
9c75e30a-a410-40f1-b653-04d532bd9144cladribine 10 MG (10) Oral Tablet PackPSN10These highlights do not include all the information needed to use MAVENCLAD safely and effectively. See full prescribing information for MAVENCLAD. MAVENCLAD ® (cladribine) tablets, for oral use Initial U.S. Approval: 199320260527
407c52d5-6498-7da5-da35-acc9ca73ced3{10 (cladribine 10 MG Oral Tablet) } PackGPCK3These highlights do not include all the information needed to use CLADRIBINE TABLETS safely and effectively. See full prescribing information for CLADRIBINE TABLETS. CLADRIBINE tablets, for oral use Initial U.S. Approval: 199320251201
407c52d5-6498-7da5-da35-acc9ca73ced3cladribine 10 MG (10) Oral Tablet PackPSN3These highlights do not include all the information needed to use CLADRIBINE TABLETS safely and effectively. See full prescribing information for CLADRIBINE TABLETS. CLADRIBINE tablets, for oral use Initial U.S. Approval: 199320251201
f1d650a5-4205-720b-f39b-4213277b6612cladribine 10 MG (10) Oral Tablet PackPSN2These highlights do not include all the information needed to use CLADRIBINE TABLETS safely and effectively. See full prescribing information for CLADRIBINE TABLETS. CLADRIBINE tablets, for oral use Initial U.S. Approval: 199320251201
f1d650a5-4205-720b-f39b-4213277b6612{10 (cladribine 10 MG Oral Tablet) } PackGPCK2These highlights do not include all the information needed to use CLADRIBINE TABLETS safely and effectively. See full prescribing information for CLADRIBINE TABLETS. CLADRIBINE tablets, for oral use Initial U.S. Approval: 199320251201
e0b363cb-db83-44d6-89d0-1f7176be7459{10 (cladribine 10 MG Oral Tablet) } PackGPCK1These highlights do not include all the information needed to use CLADRIBINE TABLETS safely and effectively. See full prescribing information for CLADRIBINE TABLETS. CLADRIBINE tablets, for oral use Initial U.S. Approval: 199320260421
e0b363cb-db83-44d6-89d0-1f7176be7459cladribine 10 MG (10) Oral Tablet PackPSN1These highlights do not include all the information needed to use CLADRIBINE TABLETS safely and effectively. See full prescribing information for CLADRIBINE TABLETS. CLADRIBINE tablets, for oral use Initial U.S. Approval: 199320260421